Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Conexeu Sciences Inc. See All Filings	D/A	2026-06-12 14:32:02 UTC
Amount To Be Raised $2,200 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-26-000034 Exclusions or Exemptions 506b Accepted Date 2026-06-12 14:32:02 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	D	2026-06-10 15:18:36 UTC
Amount To Be Raised $137,427 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-26-000033 Exclusions or Exemptions 506b Accepted Date 2026-06-10 15:18:36 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	D	2026-05-21 17:14:32 UTC
Amount To Be Raised $44,700 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-26-000028 Exclusions or Exemptions 506b Accepted Date 2026-05-21 17:14:32 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	D	2026-05-21 17:11:41 UTC
Amount To Be Raised $1,248,634 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-26-000027 Exclusions or Exemptions 506b Accepted Date 2026-05-21 17:11:41 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Conexeu Sciences Inc. See All Filings	D	2026-03-31 19:40:01 UTC
Amount To Be Raised $1,815,000 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-26-000022 Exclusions or Exemptions 506b Accepted Date 2026-03-31 19:40:01 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	D	2026-03-20 19:32:19 UTC
Amount To Be Raised $44,698 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0001062993-26-001563 Exclusions or Exemptions 506b Accepted Date 2026-03-20 19:32:19 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	D	2026-02-26 19:08:56 UTC
Amount To Be Raised $1,072,437 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-26-000015 Exclusions or Exemptions 506b Accepted Date 2026-02-26 19:08:56 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Conexeu Sciences Inc. See All Filings	D	2026-02-04 14:34:16 UTC
Amount To Be Raised $810,000 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-26-000011 Exclusions or Exemptions 506b Accepted Date 2026-02-04 14:34:16 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	D	2025-11-20 15:32:29 UTC
Amount To Be Raised $202,299 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-25-000059 Exclusions or Exemptions 506b Accepted Date 2025-11-20 15:32:29 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	D	2025-11-12 19:43:19 UTC
Amount To Be Raised $2,921,446 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-25-000054 Exclusions or Exemptions 506b Accepted Date 2025-11-12 19:43:19 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	C/A	2025-07-30 15:36:56 UTC
Financial Interest The Intermediary will receive a number of shares of common stock of the issuer that is equal to two percent (2%) of the total number of shares of common stock sold by the issuer in the offering. Filing Platform Equifund Crowd Funding Portal Inc. Offering Amount $5,000,000 CIK Number 0002066836 Filed Document 0001062993-25-013287 Accepted Date 2025-07-30 15:36:56 UTC Type of Offering C/A Security Offered Amount 10,000 Security Offered Type Common Stock State NEVADA
Conexeu Sciences Inc. See All Filings	C	2025-07-30 11:49:14 UTC
Financial Interest The Intermediary will receive a number of shares of common stock of the issuer that is equal to two percent (2%) of the total number of shares of common stock sold by the issuer in the offering. Filing Platform Equifund Crowd Funding Portal Inc. Offering Amount $5,000,000 CIK Number 0002066836 Filed Document 0001062993-25-013275 Accepted Date 2025-07-30 11:49:14 UTC Type of Offering C Security Offered Amount 2,500,000 Security Offered Type Common Stock State NEVADA
Conexeu Sciences Inc. See All Filings	D/A	2025-07-02 14:52:27 UTC
Amount To Be Raised $2,531,964 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-25-000024 Exclusions or Exemptions 506b Accepted Date 2025-07-02 14:52:27 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	D	2025-06-13 14:00:06 UTC
Amount To Be Raised $2,200 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0002060755-25-000021 Exclusions or Exemptions 506b Accepted Date 2025-06-13 14:00:06 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity
Conexeu Sciences Inc. See All Filings	D	2025-05-08 19:24:13 UTC
Amount To Be Raised $2,411,964 Associated Brokers / Dealers N/A CIK Number 0002066836 Filed Document 0001062993-25-008936 Exclusions or Exemptions 506b Accepted Date 2025-05-08 19:24:13 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEVADA Revenue or Assets Decline to Disclose Type of Security Equity